Athersys Inc., the Cleveland-based regenerative medicine company, could raise up to $12 million by selling its shares and warrants to “a single healthcare-focused U.S. institutional investor.”
The unnamed institutional investor has agreed to acquire up to 48 million shares of Athersys stock, stock equivalents and warrants for 25 cents apiece in a deal expected to close by Aug. 17, the Cleveland company said in a Monday statement.
Click here to read the complete story.
Story excerpt provided by Cleveland Business Journal.
Written by Mary Vanac.
Originally published August 15, 2022.